Pancreatic cancer: The Lancet: January 24, 2017
The Lancet in conversation with - Un podcast de The Lancet Group - Les vendredis
Catégories:
John Neoptolomos discusses the ESPAC-4 trial, investigating a chemotherapy drug combination for patients with pancreatic cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
